Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae

被引：15

作者：

Boswell, FJ ^{[1
]}

Andrews, JM ^{[1
]}

Wise, R ^{[1
]}

机构：

[1] City Hosp NHS Trust, Dept Microbiol, Birmingham B18 7QH, W Midlands, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 48卷 / 03期

关键词：

D O I：

10.1093/jac/48.3.446

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：446 / 447

页数：2

共 6 条

[1] AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].

COX, RA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3

[2] Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 [J].

Fung-Tomc, JC ;

Minassian, B ;

Kolek, B ;

Huczko, E ;

Aleksunes, L ;

Stickle, T ;

Washo, T ;

Gradelski, E ;

Valera, L ;

Bonner, DP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3351-3356

[3] Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae [J].

Gill, MJ ;

Brenwald, NP ;

Wise, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) :187-189

[4]

GILL MJ, 1998, 38 INT C ANT AG CHEM, P83

[5] Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae [J].

Pan, XS ;

Ambler, J ;

Mehtar, S ;

Fisher, LM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2321-2326

[6]

TANOVIC J, 1996, ANTIMICROBIAL AGENTS, V40, P2505

← 1 →